Comparison of AIT effectiveness and quality of life within
groups
Median TSS-6, VAS-symptom, MS and VAS-QoL scores calculated before and
during the pandemic were similar in Group 1 (p>0.05 for
each score). In Group 2, median values of VAS-symptom were higher during
the pandemic than the pre-pandemic period while TSS-6 and MS were
similar in both periods (p=0.002, p>0.05,
p>0.05). Also, median values of VAS-QoL decreased during
the pandemic compared to pre-pandemic period in the same group
(p<0.001) (Figure 1).
In adherent patients, VAS-symptom increased and VAS-QoL decreased during
the pandemic compared to the pre-pandemic period (p=0.013,
p<0.001, respectively) and the median values of TSS-6 and MS
were similar in both periods in adherent patients (p>0.05
for each comparison). In non-adherent patients, median values of TSS-6,
VAS-symptom and MSs were higher and median value of VAS-QoL was lower
during the pandemic than the pre-pandemic period (p<0.001,
p<0.001, p=0.005, p<0.001, respectively) (Figure 2).